Login / Signup

International experience with performance-based risk-sharing arrangements: implications for the Chinese innovative pharmaceutical market.

Weiwei XuJing Wu
Published in: International journal of technology assessment in health care (2020)
The implementation of PBRSAs has proven to be challenging. Although the Chinese healthcare system is not yet well equipped to implement such schemes, some recent changes may pave the way to successful PBRSAs for particular innovative products.
Keyphrases
  • primary care
  • healthcare
  • health insurance
  • health information
  • quality improvement